UTHR Annual Total Long Term Liabilities
$377.80 M
-$526.80 M-58.24%
31 December 2023
Summary:
As of January 19, 2025, UTHR annual total long term liabilities is $377.80 million, with the most recent change of -$526.80 million (-58.24%) on December 31, 2023. During the last 3 years, it has fallen by -$518.70 million (-57.86%). UTHR annual total long term liabilities is now -58.24% below its all-time high of $904.80 million, reached on December 31, 2021.UTHR Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Quarterly Long Term Liabilities
$148.80 M
-$44.90 M-23.18%
30 September 2024
Summary:
As of January 19, 2025, UTHR quarterly total long term liabilities is $148.80 million, with the most recent change of -$44.90 million (-23.18%) on September 30, 2024. Over the past year, it has dropped by -$418.60 million (-73.78%). UTHR quarterly long term liabilities is now -86.70% below its all-time high of $1.12 billion, reached on March 31, 2019.UTHR Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.2% | -73.8% |
| 3 y3 years | -57.9% | -73.8% |
| 5 y5 years | +19.3% | -82.9% |
UTHR Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.2% | at low | -83.5% | at low |
| 5 y | 5-year | -58.2% | at low | -83.5% | at low |
| alltime | all time | -58.2% | >+9999.0% | -86.7% | >+9999.0% |
United Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $148.80 M(-23.2%) |
| June 2024 | - | $193.70 M(-34.7%) |
| Mar 2024 | - | $296.50 M(-21.5%) |
| Dec 2023 | $377.80 M(-58.2%) | $377.80 M(-33.4%) |
| Sept 2023 | - | $567.40 M(-37.0%) |
| June 2023 | - | $900.00 M(+0.2%) |
| Mar 2023 | - | $898.20 M(-0.7%) |
| Dec 2022 | $904.60 M(-0.0%) | $904.60 M(+0.1%) |
| Sept 2022 | - | $903.50 M(+1.1%) |
| June 2022 | - | $893.40 M(+0.3%) |
| Mar 2022 | - | $890.90 M(-1.5%) |
| Dec 2021 | $904.80 M(+0.9%) | $904.80 M(+0.6%) |
| Sept 2021 | - | $899.20 M(+0.6%) |
| June 2021 | - | $894.00 M(+0.1%) |
| Mar 2021 | - | $893.20 M(-0.4%) |
| Dec 2020 | $896.50 M(+33.8%) | $896.50 M(+3.1%) |
| Sept 2020 | - | $869.20 M(-0.2%) |
| June 2020 | - | $870.70 M(+0.1%) |
| Mar 2020 | - | $870.10 M(+29.9%) |
| Dec 2019 | $670.00 M(+111.6%) | $670.00 M(-17.7%) |
| Sept 2019 | - | $813.90 M(-6.3%) |
| June 2019 | - | $868.60 M(-22.3%) |
| Mar 2019 | - | $1.12 B(+253.3%) |
| Dec 2018 | $316.60 M(+0.9%) | $316.60 M(-3.4%) |
| Sept 2018 | - | $327.70 M(+5.7%) |
| June 2018 | - | $310.10 M(-1.0%) |
| Mar 2018 | - | $313.20 M(-0.2%) |
| Dec 2017 | $313.70 M(+139.6%) | $313.70 M(+445.6%) |
| Sept 2017 | - | $57.50 M(+0.2%) |
| June 2017 | - | $57.40 M(0.0%) |
| Mar 2017 | - | $57.40 M(-56.1%) |
| Dec 2016 | $130.90 M(-9.1%) | $130.90 M(+24.7%) |
| Sept 2016 | - | $105.00 M(+14.1%) |
| June 2016 | - | $92.00 M(-18.0%) |
| Mar 2016 | - | $112.20 M(-22.1%) |
| Dec 2015 | $144.00 M(+25.7%) | $144.00 M(+17.5%) |
| Sept 2015 | - | $122.52 M(-13.0%) |
| June 2015 | - | $140.85 M(+3.7%) |
| Mar 2015 | - | $135.81 M(+18.6%) |
| Dec 2014 | $114.53 M(+19.8%) | $114.53 M(+20.8%) |
| Sept 2014 | - | $94.84 M(+17.5%) |
| June 2014 | - | $80.72 M(-18.2%) |
| Mar 2014 | - | $98.71 M(+3.3%) |
| Dec 2013 | $95.58 M(-73.1%) | $95.58 M(-36.5%) |
| Sept 2013 | - | $150.63 M(+0.9%) |
| June 2013 | - | $149.31 M(-58.4%) |
| Mar 2013 | - | $359.17 M(+1.2%) |
| Dec 2012 | $354.98 M(+2.6%) | $354.98 M(-1.1%) |
| Sept 2012 | - | $359.05 M(-0.0%) |
| June 2012 | - | $359.14 M(-0.6%) |
| Mar 2012 | - | $361.24 M(+4.4%) |
| Dec 2011 | $346.13 M | $346.13 M(+120.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $157.13 M(+27.9%) |
| June 2011 | - | $122.86 M(+3.0%) |
| Mar 2011 | - | $119.24 M(+0.1%) |
| Dec 2010 | $119.06 M(+74.2%) | $119.06 M(+167.0%) |
| Sept 2010 | - | $44.59 M(+12.5%) |
| June 2010 | - | $39.65 M(-42.9%) |
| Mar 2010 | - | $69.42 M(+1.6%) |
| Dec 2009 | $68.35 M(-73.9%) | $68.35 M(+6.6%) |
| Sept 2009 | - | $64.14 M(-76.3%) |
| June 2009 | - | $270.47 M(+1.8%) |
| Mar 2009 | - | $265.77 M(+1.6%) |
| Dec 2008 | $261.51 M(+1316.0%) | $261.51 M(+375.8%) |
| Sept 2008 | - | $54.97 M(+346.6%) |
| June 2008 | - | $12.31 M(-95.1%) |
| Mar 2008 | - | $251.18 M(+1260.1%) |
| Dec 2007 | $18.47 M(-92.7%) | $18.47 M(-93.1%) |
| Sept 2007 | - | $269.38 M(-0.0%) |
| June 2007 | - | $269.49 M(+5.8%) |
| Mar 2007 | - | $254.69 M(+0.6%) |
| Dec 2006 | $253.12 M(>+9900.0%) | $253.12 M(+9195.4%) |
| Sept 2006 | - | $2.72 M(+32.2%) |
| June 2006 | - | $2.06 M(+17.2%) |
| Mar 2006 | - | $1.76 M(-1.7%) |
| Dec 2005 | $1.79 M(+7.8%) | $1.79 M(+5.6%) |
| Sept 2005 | - | $1.69 M(+1.3%) |
| June 2005 | - | $1.67 M(-1.1%) |
| Mar 2005 | - | $1.69 M(+1.9%) |
| Dec 2004 | $1.66 M(+48.2%) | $1.66 M(+4.7%) |
| Sept 2004 | - | $1.58 M(+16.2%) |
| June 2004 | - | $1.36 M(+17.2%) |
| Mar 2004 | - | $1.16 M(+3.9%) |
| Dec 2003 | $1.12 M(-68.9%) | $1.12 M(+3.1%) |
| Sept 2003 | - | $1.08 M(-60.3%) |
| June 2003 | - | $2.74 M(+4.3%) |
| Mar 2003 | - | $2.62 M(-27.1%) |
| Dec 2002 | $3.60 M(-26.9%) | $3.60 M(+0.9%) |
| Sept 2002 | - | $3.57 M(+1.5%) |
| June 2002 | - | $3.51 M(+1.3%) |
| Mar 2002 | - | $3.47 M(-29.6%) |
| Dec 2001 | $4.92 M(+11.5%) | $4.92 M(+0.0%) |
| Sept 2001 | - | $4.92 M(+13.7%) |
| June 2001 | - | $4.33 M(+6.3%) |
| Mar 2001 | - | $4.07 M(-7.8%) |
| Dec 2000 | $4.42 M(+159.7%) | $4.42 M(+148.5%) |
| Sept 2000 | - | $1.78 M(-0.2%) |
| June 2000 | - | $1.78 M(-0.6%) |
| Mar 2000 | - | $1.79 M(+5.3%) |
| Dec 1999 | $1.70 M(+750.0%) | $1.70 M(-5.6%) |
| Sept 1999 | - | $1.80 M(+157.1%) |
| June 1999 | - | $700.00 K(+133.3%) |
| Mar 1999 | - | $300.00 K |
| Dec 1998 | $200.00 K | - |
FAQ
- What is United Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for United Therapeutics?
- What is United Therapeutics annual total long term liabilities year-on-year change?
- What is United Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for United Therapeutics?
- What is United Therapeutics quarterly long term liabilities year-on-year change?
What is United Therapeutics annual total long term liabilities?
The current annual total long term liabilities of UTHR is $377.80 M
What is the all time high annual total long term liabilities for United Therapeutics?
United Therapeutics all-time high annual total long term liabilities is $904.80 M
What is United Therapeutics annual total long term liabilities year-on-year change?
Over the past year, UTHR annual total long term liabilities has changed by -$526.80 M (-58.24%)
What is United Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of UTHR is $148.80 M
What is the all time high quarterly long term liabilities for United Therapeutics?
United Therapeutics all-time high quarterly total long term liabilities is $1.12 B
What is United Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, UTHR quarterly total long term liabilities has changed by -$418.60 M (-73.78%)